Caramiphen and scopolamine prevent soman-induced brain damage and cognitive dysfunction

NeuroToxicology

Volumn 23, Issue 1, 2002, Pages 7-17

  Raveh, Lily ^a   Weissman, Ben Avi ^a   Cohen, Giora ^a   Alkalay, David ^a   Rabinovitz, Ishai ^a   Sonego, Hagar ^a   Brandeis, Rachel ^a  

^a ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH   (Israel)

Author keywords

3H AMPA; 3H Ro5 4864; Caramiphen; Morris water maze; Rat; Scopolamine; Soman

Indexed keywords

4' CHLORODIAZEPAM; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; ANTICONVULSIVE AGENT; BENZODIAZEPINE RECEPTOR; CARAMIPHEN; CHOLINERGIC RECEPTOR BLOCKING AGENT; PYRIDOSTIGMINE; SCOPOLAMINE; SOMAN; TRITIUM; CYCLOPENTANE DERIVATIVE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICHOLINERGIC EFFECT; ARTICLE; ASTROCYTE; BRAIN INJURY; BRAIN MEMBRANE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG INTOXICATION; DRUG MECHANISM; DRUG RECEPTOR BINDING; FOREBRAIN; LEARNING; MALE; MEMORY; MEMORY DISORDER; MICROGLIA; NEUROPROTECTION; NEUROTOXICITY; NEUROTOXICOLOGY; NONHUMAN; PARAMETER; PRIORITY JOURNAL; RAT; TISSUE PREPARATION; ANIMAL; BRAIN HYPOXIA; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; DRUG ANTAGONISM; DRUG EFFECT; ESCAPE BEHAVIOR; MAZE TEST; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REACTION TIME; SPRAGUE DAWLEY RAT; SWIMMING;

ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANIMALS; COGNITION DISORDERS; CYCLOPENTANES; ESCAPE REACTION; HYPOXIA, BRAIN; MALE; MAZE LEARNING; PROSENCEPHALON; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; SCOPOLAMINE; SOMAN; SWIMMING;

EID: 0036560278     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-813X(02)00005-0     Document Type: Article

References (49)

1. Baudry M. Synaptic plasticity and learning and memory: 15 years of progress. Neurobiol Learn Memory 1998;70:113-8.
2. Benavides J, Fage D, Carter C, Scatton B. Peripheral type benzodiazepine binding sites are a sensitive indirect index of neuronal damage. Brain Res 1987;421:167-72.
3. Benavides J, Capdeville C, Dauphin F, Dubois A, Duverger D, Fage D, Gotti B, MacKenzie ET, Scatton B. The quantification of brain lesions with the ω3 site ligands: a critical analysis of animal models of cerebral ischemia and neurodegeneration. Brain Res 1990;522:275-89.
4. Blick DW, Murphy MR, Brown GC, Yochmowitz MG, Fanton JW, Hartgraves SL. Acute behavioral toxicity of pyridostigmine or soman in primates. Toxicol Appl Pharmacol 1994;126:311-8.
5. 1 adenosine receptor antagonist: an anatomical and behavioral study. Neuroscience 1992;48:807-12.
6. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
7. Braitman DJ, Sparenborg S. MK-801 protects against seizures induced by the cholinesterase inhibitor soman. Brain Res Bull 1989;23:145-8.
8. Brandeis R, Brandys Y, Yehuda S. The use of the Morris water maze in the study of memory and learning. Int J Neurosci 1989;48:29-69.
9. Brandeis R, Dachir S, Sapir M, Levy A, Fisher A. Reversal of age-related cognitive impairments by an M1 cholinergic agonist, AF102B. Pharmacol Biochem Behav 1990;36:89-95.
10. Brandeis R, Raveh L, Grunwald J, Cohen E, Ashani Y. Prevention of soman-induced cognitive deficits by pretreatment with human butyrylcholinesterase in rats. Pharmacol Biochem Behav 1993;46:889-96.
11. 1 agonist improves cognitive performance in rats. Pharmacol Biochem Behav 1995;51:667-74.
12. Brown MA, Brix KA. Review of health consequences from high-, intermediate- and low-level exposure to organophosphorous nerve agents. J Appl Toxicol 1998;18:393-408.
13. Capacio BR, Shih TM. Anticonvulsant actions of anticholinergic drugs in soman poisoning. Epilepsia 1991;32:604-15.
14. Carpentier P, Lambrinidis M, Blanchet G. Early dendritic changes in hippocampal pyramidal neurons (field CA1) of rats subjected to acute soman intoxication: a light microscopic study. Brain Res 1991;541:293-9.
15. Dunn MA, Sidell FR. Progress in medical defense against nerve agents. J Am Med Assoc 1989;262:649-52.
16. Filliat P, Baubichon D, Burckhart MF, Pernot-Marino I, Foquin A, Masqueliez C, Perrichon C, Carpentier P, Lallement G. Memory impairment after soman intoxication in rat: correlation with central neuropathology. Improvement with anticholinergic and antiglutamatergic therapeutics. NeuroToxicology 1999;20:535-49.
17. Grooms SY, Opitz T, Bennett MV, Zukin RS. Status epilepticus decreases glutamate receptor 2 mRNA and protein expression in hippocampal pyramidal cells before neuronal death. Proc Natl Acad Sci USA 2000;97:3631-6.
18. Heise GA, Hudson JD. Effects of pesticides and drugs on working memory in rats: continuous non-match. Pharmacol Biochem Behav 1985;23:599-605.
19. Honore T, Nielsen M. Complex structure of quisqualate-sensitive glutamate receptors in rat cortex. Neurosci Lett 1985;54:27-32.
20. 1 receptor-selective agents. Eur J Pharmacol 1993;231:485-8.
21. 3H]MK-801 with multiple states of the N-methyl-D-aspartate receptor complex of rat brain. Proc Natl Acad Sci USA 1989;86:740-4.
22. Kadar T, Cohen G, Sahar R, Alkalai D, Shapira S. Long-term study of brain lesions following soman, in comparison to DFP and metrazol poisoning. Hum Exp Toxicol 1992;11:517-23.
23. Koplovitz I, Romano JA, Stewart JR. Assessment of motor performance decrement following soman poisoning in mice. Drug Chem Toxicol 1989;12:221-35.
24. Lallement G, Carpentier P, Pernot-Marino I, Baubichon D, Collet A, Blanchet G. Involvement of the different rat hippocampal glutamatergic receptors in development of seizures induced by soman: an autoradiographic study. NeuroToxicology 1991;12:656-64.
25. Lallement G, Denoyer M, Collet A, Pernot-Marino I, Baubichon D, Monmaur P, Blanchet G. Changes in hippocampal acetylcholine and glutamate extracellular levels during soman-induced seizures: influence of septal cholinoceptive cells. Neurosci Lett 1992;139:104-7.
26. Lallement G, Delamanche IS, Pernot-Marino I, Baubichon D, Denoyer M, Carpentier P, Blanchet G. Neuroprotective activity of glutamate receptor antagonists against soman-induced hippocampal damage: quantification with an ω3 site ligand. Brain Res 1993;618:227-37.
27. Lallement G, Pernot-Marino I, Baucichon D, Burckhart MF, Carpentier P, Blanchet G. Modulation of soman-induced neuropathology with an anticonvulsant regimen. Neuroreport 1994;5:2265-8.
28. Leadbeater L, Inns RH, Rylands JM. Treatment of poisoning by soman. Fundam Appl Toxicol 1985;5:S225-31.
29. Lennox WJ, Harris LW, Talbot BG, Anderson DR. Relationship between reversible acetylcholinesterase inhibition and efficacy against soman lethality. Life Sci 1985;37:793-8.
30. McDonough Jr, JH, Smith RF, Smith CD. Behavioral correlates of soman-induced neuropathology: deficits in DRL acquisition. Toxicol Teratol 1986;8:179-87.
31. McDonough Jr, JH, Zoeffel LD, McMonagle J, Copeland TL, Smith CD, Shih TM. Anticonvulsant treatment of nerve agent seizures: anticholinergics versus diazepam in soman-intoxicated guinea pigs. Epilepsy Res 2000;38:1-14.
32. McNamara RK, Skelton RW. The neuropharmacological and neurochemical basis of place learning in the Morris water maze. Brain Res Rev 1993;18:33-49.
33. Moore DH, Clifford CB, Crawford IT, Cole GM, Baggett JM. Review of nerve agent inhibitors and reactivators of acetylcholinesterase. In: Quinn DM, Balasubramanian AS, Doctor BP, Taylor P, editors. Enzymes of the cholinesterase family. New York: Plenum Press, 1995. p. 297-304.
34. Morris RGM, Anderson E, Lynch GS, Baudry M. Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5. Nature 1986;319:774-6.
35. 3H]AMPA binding to glutamate receptor subpopulations in rat brain. Brain Res 1987;402:243-54.
36. Ong WY, Leong SK, Garey LJ, Reynolds R, Liang AW. An immunocytochemical study of glutamate receptors and glutamine synthetase in the hippocampus of rats injected with kainate. Exp Brain Res 1996;109:251-67.
37. Philippens IHCHM, Melchers BPC, De Groot DMG, Wolthuis OL. Behavioral performance, brain histology, and EEG sequels after immediate combined atropine/diazepam treatment of soman-intoxicated rats. Pharmacol Biochem Behav 1992;42:711-9.
38. Raveh L, Chapman S, Cohen G, Alkalay D, Gilat E, Rabinovitz I, Weissman BA. The involvement of the NMDA receptor complex in the protective effect of anticholinergic drugs against soman poisoning. NeuroToxicology 1999;20:535-49.
39. Riedel G, Micheau J, Lam AGM, Roloff EV, Martin SJ, Bridge H, deHoz L, Poeschel B, McCulloch J, Morris RGM. Reversible neural inactivation reveals hippocampal participation in several memory processes. Nat Neurosci 1999;2:898-905.
40. Shih TM, McDonough Jr, JH. Organophosphorus nerve agentsinduced seizures and efficacy of atropine sulfate as anticonvulsant treatment. Pharmacol Biochem Behav 1999;64:147-53.
41. Smith G. Animal models of Alzheimer's disease: experimental cholinergic denervation. Brain Res Rev 1988;13:103-18.
42. Stephenson DT, Schoder DA, Smalstig EB, Mincy R, Gehler DR, Clemens JA. Peripheral benzodiazepine receptors are colocalized with activated microglia following transient global forebrain ischemia in the rat. J Neurosci 1995;15:5263-74.
43. Syapin PJ, Skolnick P. Characterization of benzodiazepine binding sites in cultured cells of neuronal origin. J Neurosci 1979;32:1047-51.
44. Taylor P. Anticholinesterase agents. In: Goodman LS, Gilman AG, editors. The pharmacological basis of therapeutics. 9th ed. New York: McGraw-Hill, 1996. p. 161-77.
45. Tortella FC, WitKin JM, Musacchio JM. Caramiphen: a non-opioid antitussive with potent anticonvulsant properties in rats. Eur J Pharmacol 1988;155:69-75.
46. 123I]iodo-PK-11195: a potential agent for SPET imaging of the peripheral benzodiazepine receptor. Eur J Nucl Med 2000;27:1326-33.
47. Weissman BA, Cott J, Hommer D, Paul SM, Skolnick P. Electrophysiological and pharmacological actions of the convulsant benzodiazepine Ro5-4864. Eur J Pharmacol 1984; 97:257-63.
48. Winer BJ. Statistical principles in experimental design. New York: McGraw-Hill, 1971. p. 559-71.
49. Zimmer LA, Ennis M, Shipley MT. Soman-induced seizures rapidly activate astrocytes and microglia in discrete brain regions. J Comp Neurol 1997;378:482-92.